Exact Mass: 296.0923
Exact Mass Matches: 296.0923
Found 144 metabolites which its exact mass value is equals to given mass value 296.0923
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Nitrophenyl-3-ketovalidamine
Tyrosyl-Aspartate
Tyrosyl-Aspartate is a dipeptide composed of tyrosine and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Aspartyl-Tyrosine
Aspartyl-Tyrosine is a dipeptide composed of aspartate and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
4-Carboxynevirapine
4-Carboxynevirapine is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)
1-iodo-2-methylundecane
1-iodo-2-methylundecane is classified as a member of the Organoiodides. Organoiodides are compounds containing a chemical bond between a carbon atom and an iodine atom
Penicillamine disulfide
Bentazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Taltrimide
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
gamma-Aminobutyric acid-betaxanthin
(+)-methyl 3-acetoxy-3-(7-methoxy-1,3-benzodioxol-5-yl)propanoate
5,7-dimethoxy-6-(1,2,3-trihydroxypropyl)-2H-1-benzopyran-2-one
methyl 2-[(3-formamido-2-hydroxybenzoyl)amino]-3-hydroxybutanoate
OCP_297.1002_16.5
CONFIDENCE Identification confirmed with Reference Standard (Level 1); INTERNAL_ID 1302
Asp-tyr
A dipeptide composed of L-aspartic acid and L-tyrosine joined by a peptide linkage.
3-(Dimethylamino)-1-(10H-phenothiazin-2-yl)-2-propen-1-one
(R)-1-(3-(6-(TRIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOL-2-YL)ISOXAZOL-5-YL)ETHANAMINE
5-(4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YL)-2-FLUOROBENZONITRILE
2-((3-(Trifluoromethyl)phenoxy)methyl)phenylboronic acid
1-BENZYL-1,2,3,4-TETRAHYDRO-QUINOXALINE DIHYDROCHLORIDE
Methyl 2-(tert-Butoxycarbonylamino)-3-nitrobenzoate
1-(5-Aminopentyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate
(4-(BENZYLOXY)-2-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
[[4-(4-diazonioimino-3-methoxycyclohexa-2,5-dien-1-ylidene)-2-methoxycyclohexa-2,5-dien-1-ylidene]hydrazinylidene]azanide
3-(4-METHOXYPHENYL)-5-METHYLTHIO-1-PHENYL-1H-PYRAZOLE
(3-Chloro-4-Methoxycarbonyl)Benzeneboronic Acid Pinacol Ester
2,4-DIOXO-4-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRIC ACID METHYL ESTER
methyl 3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
sodium,2-hydroxypropyl prop-2-enoate,prop-2-enoate,prop-2-enoic acid
4-bromo-2-((cyclohexyl(methyl)amino)methyl)aniline
5-(4-METHOXYPHENYL)-3-METHYLTHIO-1-PHENYL-1H-PYRAZOLE
[4-[(3-fluorophenyl)methyl]morpholin-2-yl]methanamine,dihydrochloride
tert-butoxycarbonylamino-(4-nitro-phenyl)-acetic acid
Ethyl 4-[2-(methylsulfonyl)ethyl]-1H-pyrrolo[2,3-b]pyridine-2-car boxylate
(4-(Benzyloxy)-3-(trifluoromethyl)phenyl)boronic acid
4-((3-AMINOBENZO[E][1,2,4]TRIAZIN-7-YL)OXY)-N-METHYLPICOLINAMIDE
3-(4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YL)-5-FLUOROBENZONITRILE
4,5-Dihydro-alpha,alpha,3-trimethyl-5-oxo-1-phenyl-1H-pyrazole-4-methanesulfonic acid
1-Benzyl-2,3-dihydro-1H-indol-6-ylamine dihydrochloride
N-[4-[(4-nitrophenyl)diazenyl]phenyl]prop-2-enamide
2-(4-(TERT-BUTOXYCARBONYLAMINO)-2-NITROPHENYL)ACETIC ACID
1-(2,7-Dimethyl-3-imidazo[1,2-a]pyridinyl)-2-(phenylthio)ethanone
4-(4-(2-Chlorophenyl)-1-piperazinyl)-4-oxobutanoic acid
7-(Aminomethyl)-6-(2-Chlorophenyl)-1-Methyl-1h-Benzimidazole-5-Carbonitrile
Bentazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
gamma-Aminobutyric acid-betaxanthin
3-[3-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]propanoyl]benzoic acid
2-[3-(Formylamino)-2-hydroxybenzoylamino]-3-hydroxybutanoic acid methyl ester
4-Methyl-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]quinolin-2-amine
6-(4-Ethenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
6-(3-Ethenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
1-iodo-2-methylundecane
An iodoalkane that is undecane substituted by an iodo group at position 1 and a methyl group at position 2. Metabolite observed in cancer metabolism.
TCS1105
TCS1105 is a benzodiazepine ligand with agonist for α2-subunit containing GABAA receptors and antagonist for α1-subunit containing GABAA receptors. TCS1105 reduces anxiety-like behavior in mice. TCS1105 enhances offensive behavior and social dominance. TCS1105 blocks Sema3A induced AGC (axonal growth cones) collapse in a concentration-dependent fashion[1][2].